Effects of cognitive rehabilitation in Parkinson disease: a meta-analysis.


Journal

Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology
ISSN: 1590-3478
Titre abrégé: Neurol Sci
Pays: Italy
ID NLM: 100959175

Informations de publication

Date de publication:
Apr 2022
Historique:
received: 18 10 2021
accepted: 19 11 2021
pubmed: 1 2 2022
medline: 16 3 2022
entrez: 31 1 2022
Statut: ppublish

Résumé

Cognitive symptoms are common in Parkinson's disease (PD) and affect patients' quality of life. Pharmacological interventions often do not improve such deficits that might benefit of cognitive rehabilitation. However, previous meta-analysis on this topic reported inconsistent results. Clarifying the efficacy of cognitive rehabilitation would be pivotal to optimize treatment and reduce care's costs. This meta-analysis aims at determining whether current literature lays in favor of the effectiveness of cognitive rehabilitation in PD and at understanding whether its effect might change depending on the trained cognitive domain. We searched online databases for studies concerning cognitive rehabilitation in PD. Fourteen studies encompassing 767 participants were included. Analyses were conducted for each cognitive domain separately, examining several neuropsychological measures for each function. We found that rehabilitation improves global cognition, executive functions, and long- and short-term memory. The current body of research indicates that cognitive rehabilitation improves specific cognitive deficits in PD and that it should be tailored on patients' specific impairments. These interventions should be employed considering that not all the cognitive domains might benefit of a cognitive training. Finally, the high heterogeneity among studies suggests the need for more controlled clinical trials.

Sections du résumé

BACKGROUND AND OBJECTIVES OBJECTIVE
Cognitive symptoms are common in Parkinson's disease (PD) and affect patients' quality of life. Pharmacological interventions often do not improve such deficits that might benefit of cognitive rehabilitation. However, previous meta-analysis on this topic reported inconsistent results. Clarifying the efficacy of cognitive rehabilitation would be pivotal to optimize treatment and reduce care's costs. This meta-analysis aims at determining whether current literature lays in favor of the effectiveness of cognitive rehabilitation in PD and at understanding whether its effect might change depending on the trained cognitive domain.
METHODS METHODS
We searched online databases for studies concerning cognitive rehabilitation in PD. Fourteen studies encompassing 767 participants were included. Analyses were conducted for each cognitive domain separately, examining several neuropsychological measures for each function.
RESULTS RESULTS
We found that rehabilitation improves global cognition, executive functions, and long- and short-term memory.
CONCLUSION CONCLUSIONS
The current body of research indicates that cognitive rehabilitation improves specific cognitive deficits in PD and that it should be tailored on patients' specific impairments. These interventions should be employed considering that not all the cognitive domains might benefit of a cognitive training. Finally, the high heterogeneity among studies suggests the need for more controlled clinical trials.

Identifiants

pubmed: 35098360
doi: 10.1007/s10072-021-05772-4
pii: 10.1007/s10072-021-05772-4
doi:

Types de publication

Journal Article Meta-Analysis Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

2323-2337

Subventions

Organisme : Ministero della Salute
ID : GR-2018-12367927

Commentaires et corrections

Type : ErratumIn

Informations de copyright

© 2021. Fondazione Società Italiana di Neurologia.

Références

Poewe W, Seppi K, Tanner CM, Halliday GM, Brundin P, Volkmann J, Schrag AE, Lang AE (2017) Parkinson disease. Nat Rev Dis Prim. https://doi.org/10.1038/nrdp.2017.13
doi: 10.1038/nrdp.2017.13 pubmed: 28332488
Postuma RB, Berg D, Stern M, Poewe W, Olanow CW, Oertel W, Obeso J, Marek K, Litvan I, Lang AE, Halliday G, Goetz CG, Gasser T, Dubois B, Chan P, Bloem BR, Adler CH, Deuschl G (2015) MDS clinical diagnostic criteria for Parkinson’s disease. Mov Disord. https://doi.org/10.1002/mds.26424
doi: 10.1002/mds.26424 pubmed: 26474317 pmcid: 4822999
Hiseman JP, Fackrell R (2017) Caregiver Burden and the Nonmotor Symptoms of Parkinson’s Disease. Int Rev Neurobiol. https://doi.org/10.1016/bs.irn.2017.05.035
doi: 10.1016/bs.irn.2017.05.035 pubmed: 28802929
Litvan I, Aarsland D, Adler CH, Goldman JG, Kulisevsky J, Mollenhauer B, Rodriguez-Oroz MC, Tröster AI, Weintraub D (2011) MDS task force on mild cognitive impairment in Parkinson’s disease: Critical review of PD-MCI. Mov Disord 26:1814–1824. https://doi.org/10.1002/mds.23823
doi: 10.1002/mds.23823 pubmed: 21661055 pmcid: 3181006
Baiano C, Barone P, Trojano L, Santangelo G (2020) Prevalence and clinical aspects of mild cognitive impairment in Parkinson’s disease: A meta-analysis. Mov Disord. https://doi.org/10.1002/mds.27902
doi: 10.1002/mds.27902 pubmed: 31743500
Barone P, Aarsland D, Burn D, Emre M, Kulisevsky J, Weintraub D (2011) Cognitive impairment in nondemented Parkinson’s disease. Mov Disord. https://doi.org/10.1002/mds.23919
doi: 10.1002/mds.23919 pubmed: 22170277
Muslimović D, Post B, Speelman JD, Schmand B (2005) Cognitive profile of patients with newly diagnosed Parkinson disease. Neurology. https://doi.org/10.1212/01.wnl.0000180516.69442.95
doi: 10.1212/01.wnl.0000180516.69442.95 pubmed: 16247051
Seppi K, Weintraub D, Coelho M, Perez-Lloret S, Fox SH, Katzenschlager R, Hametner EM, Poewe W, Rascol O, Goetz CG, Sampaio C (2011) The movement disorder society evidence-based medicine review update: Treatments for the non-motor symptoms of Parkinson’s disease. Mov Disord. https://doi.org/10.1002/mds.23884
doi: 10.1002/mds.23884 pubmed: 22161875 pmcid: 4020145
Bahar-Fuchs A, Martyr A, Goh AMY, Sabates J, Clare L (2019) Cognitive training for people with mild to moderate dementia. Cochrane Database Syst Rev. https://doi.org/10.1002/14651858.CD013069.pub2
doi: 10.1002/14651858.CD013069.pub2 pubmed: 30909318 pmcid: 6681837
Mowszowski L, Batchelor J, Naismith SL (2010) Early intervention for cognitive decline: Can cognitive training be used as a selective prevention technique? Int Psychogeriatrics. https://doi.org/10.1017/S1041610209991748
doi: 10.1017/S1041610209991748
Chapman SB, Aslan S, Spence JS, Hart JJ, Bartz EK, Didehbani N, Keebler MW, Gardner CM, Strain JF, Defina LF, Lu H (2015) Neural mechanisms of brain plasticity with complex cognitive training in healthy seniors. Cereb Cortex. https://doi.org/10.1093/cercor/bht234
doi: 10.1093/cercor/bht234 pubmed: 25662716 pmcid: 4830283
Nombela C, Bustillo PJ, Castell PF, Sanchez L, Medina V, Herrero MT (2011) Cognitive rehabilitation in Parkinson’s disease: Evidence from neuroimaging. Front Neurol. https://doi.org/10.3389/fneur.2011.00082
doi: 10.3389/fneur.2011.00082 pubmed: 22203816 pmcid: 3244758
Calleo J, Burrows C, Levin H, Marsh L, Lai E, York MK (2012) Cognitive rehabilitation for executive dysfunction in Parkinson’s disease: Application and current directions. Parkinsons Dis. https://doi.org/10.1155/2012/512892
doi: 10.1155/2012/512892 pubmed: 22135762 pmcid: 3458295
Leung IHK, Walton CC, Hallock H, Lewis SJG, Valenzuela M, Lampit A (2015) Cognitive training in Parkinson disease: A systematic review and meta-analysis. Neurology 85:1843–1851. https://doi.org/10.1212/WNL.0000000000002145
doi: 10.1212/WNL.0000000000002145 pubmed: 26519540 pmcid: 4662707
Orgeta V, McDonald KR, Poliakoff E, Hindle JV, Clare L, Leroi I (2020) Cognitive training interventions for dementia and mild cognitive impairment in Parkinson’s disease. Cochrane Database Syst, Rev
doi: 10.1002/14651858.CD011961.pub2
Saredakis D, Collins-Praino LE, Gutteridge DS, Stephan BCM, Keage HAD (2019) Conversion to MCI and dementia in Parkinson’s disease: a systematic review and meta-analysis. Park Relat Disord. https://doi.org/10.1016/j.parkreldis.2019.04.020
doi: 10.1016/j.parkreldis.2019.04.020
Page MJ, Moher D, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, Shamseer L, Tetzlaff JM, Akl EA, Brennan SE, Chou R, Glanville J, Grimshaw JM, Hróbjartsson A, Lalu MM, Li T, Loder EW, Mayo-Wilson E, McDonald S, McGuinness LA, Stewart LA, Thomas J, Tricco AC, Welch VA, Whiting P, McKenzie JE (2021) PRISMA 2020 explanation and elaboration: updated guidance and exemplars for reporting systematic reviews. BMJ 372:n160. https://doi.org/10.1136/bmj.n160
doi: 10.1136/bmj.n160 pubmed: 33781993 pmcid: 8005925
Corbett MS, Higgins JPT, Woolacott NF (2014) Assessing baseline imbalance in randomised trials: Implications for the Cochrane risk of bias tool. Res Synth Methods. https://doi.org/10.1002/jrsm.1090
doi: 10.1002/jrsm.1090 pubmed: 26054027
>R Core Team (2020), R: A language and environment for statistical computing., R A Lang. Environ. Stat. Comput. R Found. Stat. Comput. Vienna, Austria. (2020)
Shim SR, Kim SJ (2019) Intervention meta-analysis: application and practice using R software. Epidemiol Health. https://doi.org/10.4178/epih.e2019008
doi: 10.4178/epih.e2019008 pubmed: 30999740 pmcid: 6635665
Higgins JPT, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, Welch VA (2019). Cochrane handbook for systematic reviews of interventions. https://doi.org/10.1002/9781119536604
doi: 10.1002/9781119536604
Higgins JPT, Thompson SG, Deeks JJ, Altman DG (2003) Measuring inconsistency in meta-analyses. Br Med J. https://doi.org/10.1136/bmj.327.7414.557
doi: 10.1136/bmj.327.7414.557
Lewis S, Clarke M (2001) Forest plots: Trying to see the wood and the trees. Br Med J. https://doi.org/10.1136/bmj.322.7300.1479
doi: 10.1136/bmj.322.7300.1479
Egger M, Smith GD, Phillips AN (1997) Meta-analysis: Principles and procedures. Br Med J. https://doi.org/10.1136/bmj.315.7121.1533
doi: 10.1136/bmj.315.7121.1533
Naismith SL, Mowszowski L, Diamond K, Lewis SJG (2013) Improving memory in Parkinson’s disease: A healthy brain ageing cognitive training program. Mov Disord. https://doi.org/10.1002/mds.25457
doi: 10.1002/mds.25457 pubmed: 23630134
Vlagsma TT, Duits AA, Dijkstra HT, van Laar T, Spikman JM (2020) Effectiveness of ReSET; a strategic executive treatment for executive dysfunctioning in patients with Parkinson’s disease. Neuropsychol Rehabil 30:67–84. https://doi.org/10.1080/09602011.2018.1452761
doi: 10.1080/09602011.2018.1452761 pubmed: 29566588
Edwards JD, Hauser RA, O’Connor ML, Valdés EG, Zesiewicz TA, Uc EY (2013) Randomized trial of cognitive speed of processing training in Parkinson disease. Neurology. https://doi.org/10.1212/WNL.0b013e3182a823ba
doi: 10.1212/WNL.0b013e3182a823ba pubmed: 24304598 pmcid: 3812102
Reuter I, Mehnert S, Sammer G, Oechsner M, Engelhardt M (2012) Efficacy of a multimodal cognitive rehabilitation including psychomotor and endurance training in parkinsons disease. J Aging Res. https://doi.org/10.1155/2012/235765
doi: 10.1155/2012/235765 pubmed: 23304505 pmcid: 3523558
De Luca R, Latella D, Maggio MG, Di Lorenzo G, Maresca G, Sciarrone F, Militi D, Bramanti P, Calabrò RS (2019) Computer assisted cognitive rehabilitation improves visuospatial and executive functions in Parkinson’s disease: Preliminary results. NeuroRehabilitation 45:285–290. https://doi.org/10.3233/NRE-192789
doi: 10.3233/NRE-192789 pubmed: 31498141
Maggio MG, De Cola MC, Latella D, Maresca G, Finocchiaro C, La Rosa G, Cimino V, Sorbera C, Bramanti P, De Luca R, Calabrò RS (2018) What About the Role of Virtual Reality in Parkinson Disease’s Cognitive Rehabilitation? Preliminary Findings From a Randomized Clinical Trial. J Geriatr Psychiatry Neurol 31:312–318. https://doi.org/10.1177/0891988718807973
doi: 10.1177/0891988718807973 pubmed: 30360679
Petrelli A, Kaesberg S, Barbe MT, Timmermann L, Fink GR, Kessler J, Kalbe E (2014) Effects of cognitive training in Parkinson’s disease: a randomized controlled trial. Parkinsonism Relat Disord 20:1196–1202. https://doi.org/10.1016/j.parkreldis.2014.08.023
doi: 10.1016/j.parkreldis.2014.08.023 pubmed: 25242806
Petrelli A, Kaesberg S, Barbe MT, Timmermann L, Rosen JB, Fink GR, Kessler J, Kalbe E (2015) Cognitive training in Parkinson’s disease reduces cognitive decline in the long term. Eur J Neurol 22:640–647. https://doi.org/10.1111/ene.12621
doi: 10.1111/ene.12621 pubmed: 25534579
Barboza NM, Terra MB, Bueno MEB, Christofoletti G, Smaili SM (2019) Physiotherapy Versus Physiotherapy Plus Cognitive Training on Cognition and Quality of Life in Parkinson Disease: Randomized Clinical Trial. Am J Phys Med Rehabil 98:460–468. https://doi.org/10.1097/PHM.0000000000001128
doi: 10.1097/PHM.0000000000001128 pubmed: 30640726
París AP, Saleta HG, de la Cruz Crespo M, Maraver E, Silvestre MG, Freixa CP, Torrellas SA, Pont MF, Nadal SA, Garcia MVP, Bartolomé VL, Fernández A.R. Bayés (2011) Blind randomized controlled study of the efficacy of cognitive training in Parkinson’s disease. Mov Disord 26:1251–1258. https://doi.org/10.1002/mds.23688
doi: 10.1002/mds.23688 pubmed: 21442659
Peña J, Ibarretxe-Bilbao N, García-Gorostiaga I, Gomez-Beldarrain MA, Díez-Cirarda M, Ojeda N (2014) Improving functional disability and cognition in Parkinson disease: randomized controlled trial. Neurology 83:2167–2174. https://doi.org/10.1212/WNL.0000000000001043
doi: 10.1212/WNL.0000000000001043 pubmed: 25361785 pmcid: 4276404
Zimmermann R, Gschwandtner U, Benz N, Hatz F, Schindler C, Taub E, Fuhr P (2014) Cognitive training in Parkinson disease: Cognition-specific vs nonspecific computer training. Neurology. https://doi.org/10.1212/WNL.0000000000000287
doi: 10.1212/WNL.0000000000000287 pubmed: 25186864 pmcid: 3932139
Fellman D, Salmi J, Ritakallio L, Ellfolk U, Rinne JO, Laine M (2020) Training working memory updating in Parkinson’s disease: A randomised controlled trial. Neuropsychol Rehabil. https://doi.org/10.1080/09602011.2018.1489860
doi: 10.1080/09602011.2018.1489860 pubmed: 29968519
Alloni A, Quaglini S, Panzarasa S, Sinforiani E, Bernini S (2018) Evaluation of an ontology-based system for computerized cognitive rehabilitation. Int J Med Inform. https://doi.org/10.1016/j.ijmedinf.2018.04.005
doi: 10.1016/j.ijmedinf.2018.04.005 pubmed: 29779721
Martinez-Horta S, Kulisevsky J (2019) Mild cognitive impairment in Parkinson’s disease. J Neural Transm. https://doi.org/10.1007/s00702-019-02003-1
doi: 10.1007/s00702-019-02003-1 pubmed: 30963293
Hoops S, Nazem S, Siderowf AD, Duda JE, Xie SX, Stern MB, Weintraub D (2009) Validity of the MoCA and MMSE in the detection of MCI and dementia in Parkinson disease. Neurology. https://doi.org/10.1212/WNL.0b013e3181c34b47
doi: 10.1212/WNL.0b013e3181c34b47 pubmed: 19933974 pmcid: 2788810
Skorvanek M, Goldman JG, Jahanshahi M, Marras C, Rektorova I, Schmand B, van Duijn E, Goetz CG, Weintraub D, Stebbins GT, Martinez-Martin P (2018) Global scales for cognitive screening in Parkinson’s disease: Critique and recommendations. Mov Disord. https://doi.org/10.1002/mds.27233
doi: 10.1002/mds.27233 pubmed: 30230627
Kudlicka A, Clare L, Hindle JV (2011) Executive functions in Parkinson’s disease: Systematic review and meta-analysis. Mov Disord. https://doi.org/10.1002/mds.23868
doi: 10.1002/mds.23868 pubmed: 21971697
Ferrazzoli D, Ortelli P, Zivi I, Cian V, Urso E, Ghilardi MF, Maestri R, Frazzitta G (2018) Efficacy of intensive multidisciplinary rehabilitation in Parkinson’s disease: A randomised controlled study. J Neurol Neurosurg Psychiatry. https://doi.org/10.1136/jnnp-2017-316437
doi: 10.1136/jnnp-2017-316437 pubmed: 29321141
Gates NJ, Sachdev PS, Fiatarone Singh MA, Valenzuela M (2011) Cognitive and memory training in adults at risk of dementia: A systematic review. BMC Geriatr. https://doi.org/10.1186/1471-2318-11-55
doi: 10.1186/1471-2318-11-55 pubmed: 21942932 pmcid: 3191477
Biundo R, Weis L, Abbruzzese G, Calandra-Buonaura G, Cortelli P, Jori MC, Lopiano L, Marconi R, Matinella A, Morgante F, Nicoletti A, Tamburini T, Tinazzi M, Zappia M, Vorovenci RJ, Antonini A (2017) Impulse control disorders in advanced Parkinson’s disease with dyskinesia: The ALTHEA study. Mov Disord. https://doi.org/10.1002/mds.27181
doi: 10.1002/mds.27181 pubmed: 28960475
A’Campo LEI, Wekking EM, Spliethoff-Kamminga NGA, Le Cessie S, Roos RAC (2010) The benefits of a standardized patient education program for patients with Parkinson’s disease and their caregivers. Park Relat Disord. https://doi.org/10.1016/j.parkreldis.2009.07.009
doi: 10.1016/j.parkreldis.2009.07.009

Auteurs

Andreina Giustiniani (A)

Neuropsychology Department, IRCCS San Camillo Hospital, via Alberoni 70, 30126, Venice, Italy. andreina.giustiniani@hsancamillo.it.

Lorenza Maistrello (L)

Neuropsychology Department, IRCCS San Camillo Hospital, via Alberoni 70, 30126, Venice, Italy.

Laura Danesin (L)

Neuropsychology Department, IRCCS San Camillo Hospital, via Alberoni 70, 30126, Venice, Italy.

Elena Rigon (E)

Neuropsychology Department, IRCCS San Camillo Hospital, via Alberoni 70, 30126, Venice, Italy.

Francesca Burgio (F)

Neuropsychology Department, IRCCS San Camillo Hospital, via Alberoni 70, 30126, Venice, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH